The search for predictive patterns in ovarian cancer: Proteomics meets bioinformatics

被引：25

作者：

Daly, MB

Ozols, RF

机构：

[1] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA

[2] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA

来源：

CANCER CELL | 2002年 / 1卷 / 02期

关键词：

D O I：

10.1016/S1535-6108(02)00037-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Proteomic patterns in serum that discriminate between malignant and benign ovaries may provide a powerful tool for screening in high risk women.

引用

页码：111 / 112

页数：2

共 13 条

[1]

EASTON DF, 1995, AM J HUM GENET, V56, P265

[2]

JACOBS I, 1989, HUM REPROD, V4, P1

[3]

Menon U, 2000, PRINCIPLES PRACTICE, P165

[4] Future for ovarian cancer screening: Novel markers from emerging technologies of transcriptional profiling and proteomics [J].

Mills, GB ;

Bast, RC ;

Srivastava, S .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (19) :1437-1439

[5] Prostasin, a potential serum marker for ovarian cancer: Identification through microarray technology [J].

Mok, SC ;

Chao, J ;

Skates, S ;

Wong, KK ;

Yiu, GK ;

Muto, MG ;

Berkowitz, RS ;

Cramer, DW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (19) :1458-1464

[6]

Ozols RF, 2000, Journal of ovarian research, V3rd, P981

[7] Use of proteomic patterns in serum to identify ovarian cancer [J].

Petricoin, EF ;

Ardekani, AM ;

Hitt, BA ;

Levine, PJ ;

Fusaro, VA ;

Steinberg, SM ;

Mills, GB ;

Simone, C ;

Fishman, DA ;

Kohn, EC ;

Liotta, LA .

LANCET, 2002, 359 (9306) :572-577

[8]

PIVER MS, 1993, GYNECOL ONCOL, P253

[9]

Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO

[10]

2-I

← 1 2 →